NO328218B1 - Kinuklidinforbindelser, anvendelse derav, fremgangsmater for fremstilling derav, og medisinske preparater omfattende slike - Google Patents
Kinuklidinforbindelser, anvendelse derav, fremgangsmater for fremstilling derav, og medisinske preparater omfattende slike Download PDFInfo
- Publication number
- NO328218B1 NO328218B1 NO20021528A NO20021528A NO328218B1 NO 328218 B1 NO328218 B1 NO 328218B1 NO 20021528 A NO20021528 A NO 20021528A NO 20021528 A NO20021528 A NO 20021528A NO 328218 B1 NO328218 B1 NO 328218B1
- Authority
- NO
- Norway
- Prior art keywords
- group
- benzyl
- pyridyl
- quinuclidinol
- ethynyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 324
- 238000002360 preparation method Methods 0.000 title claims description 55
- 238000000034 method Methods 0.000 title claims description 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 56
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims abstract description 40
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract description 28
- 150000003839 salts Chemical class 0.000 claims abstract description 20
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 9
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 claims abstract description 8
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims abstract description 7
- -1 morpholinoamino group Chemical group 0.000 claims description 133
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 59
- 125000005843 halogen group Chemical group 0.000 claims description 29
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 25
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 24
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 23
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 20
- 125000001424 substituent group Chemical group 0.000 claims description 20
- 239000003054 catalyst Substances 0.000 claims description 14
- 125000004076 pyridyl group Chemical group 0.000 claims description 14
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 13
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 12
- 125000002541 furyl group Chemical group 0.000 claims description 12
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 11
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical group C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims description 11
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 10
- 125000003386 piperidinyl group Chemical group 0.000 claims description 10
- 125000005412 pyrazyl group Chemical group 0.000 claims description 10
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 10
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 10
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 9
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 8
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 7
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 7
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000002393 azetidinyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 claims description 6
- 125000005879 dioxolanyl group Chemical group 0.000 claims description 6
- 125000002883 imidazolyl group Chemical group 0.000 claims description 6
- 125000004043 oxo group Chemical group O=* 0.000 claims description 6
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 6
- 125000000335 thiazolyl group Chemical group 0.000 claims description 6
- 125000001544 thienyl group Chemical group 0.000 claims description 6
- 125000005505 thiomorpholino group Chemical group 0.000 claims description 6
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 5
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 5
- 125000005842 heteroatom Chemical group 0.000 claims description 5
- 208000031225 myocardial ischemia Diseases 0.000 claims description 5
- 125000006625 (C3-C8) cycloalkyloxy group Chemical group 0.000 claims description 4
- 206010002383 Angina Pectoris Diseases 0.000 claims description 4
- 208000025494 Aortic disease Diseases 0.000 claims description 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 4
- 208000005764 Peripheral Arterial Disease Diseases 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 4
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 4
- 208000029078 coronary artery disease Diseases 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- 125000005495 pyridazyl group Chemical group 0.000 claims description 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 4
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 3
- JVGRDOFFGUQJBK-UHFFFAOYSA-N 3-[2-(2-benzyl-6-morpholin-4-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CC=C(N2CCOCC2)N=C1CC1=CC=CC=C1 JVGRDOFFGUQJBK-UHFFFAOYSA-N 0.000 claims description 3
- FSGDQWMFZOOLBG-UHFFFAOYSA-N 3-[2-(3-benzyl-5-phenylpyridin-2-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=NC=C(C=2C=CC=CC=2)C=C1CC1=CC=CC=C1 FSGDQWMFZOOLBG-UHFFFAOYSA-N 0.000 claims description 3
- QTFCEFBHONJSIX-UHFFFAOYSA-N 3-[2-(4-benzyl-2-phenylpyrimidin-5-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2C=CC=CC=2)N=C1CC1=CC=CC=C1 QTFCEFBHONJSIX-UHFFFAOYSA-N 0.000 claims description 3
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims description 3
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 150000001879 copper Chemical class 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- CPPMWGABDHPRII-RCZVLFRGSA-N (3r)-1-[6-benzyl-5-[2-[(3r)-3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl]ethynyl]pyridin-2-yl]-3-hydroxypyrrolidin-2-one Chemical compound O=C1[C@H](O)CCN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 CPPMWGABDHPRII-RCZVLFRGSA-N 0.000 claims description 2
- SVFDZGVFNLKIIV-ZEQKJWHPSA-N (3r)-1-[6-benzyl-5-[2-[(3r)-3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl]ethynyl]pyridin-2-yl]-3-methoxypyrrolidin-2-one Chemical compound O=C1[C@H](OC)CCN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 SVFDZGVFNLKIIV-ZEQKJWHPSA-N 0.000 claims description 2
- NPQXECSOLBQJBZ-AREMUKBSSA-N (3r)-3-[2-(4-benzyl-6-pyridin-2-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC1=CN=C(C=2N=CC=CC=2)C=C1CC1=CC=CC=C1 NPQXECSOLBQJBZ-AREMUKBSSA-N 0.000 claims description 2
- NQHGFEKZZYGIFD-AREMUKBSSA-N (3r)-3-[2-(4-benzyl-6-pyridin-3-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC1=CN=C(C=2C=NC=CC=2)C=C1CC1=CC=CC=C1 NQHGFEKZZYGIFD-AREMUKBSSA-N 0.000 claims description 2
- GADQDLHZTIBVTE-DGWZTRNLSA-N (3r)-3-[2-[2-benzyl-5-bromo-6-[(3r,4r)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@@H](O)[C@H](OC)CN1C1=NC(CC=2C=CC=CC=2)=C(C#C[C@]2(O)C3CCN(CC3)C2)C=C1Br GADQDLHZTIBVTE-DGWZTRNLSA-N 0.000 claims description 2
- QDCHGOWVIUUNKZ-AREMUKBSSA-N (3r)-3-[2-[2-benzyl-5-chloro-6-(1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC1=CC(Cl)=C(N2CC3(CC2)OCCO3)N=C1CC1=CC=CC=C1 QDCHGOWVIUUNKZ-AREMUKBSSA-N 0.000 claims description 2
- NHJBORAJQCASEU-DGWZTRNLSA-N (3r)-3-[2-[2-benzyl-5-chloro-6-[(3r,4r)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@@H](O)[C@H](OC)CN1C1=NC(CC=2C=CC=CC=2)=C(C#C[C@]2(O)C3CCN(CC3)C2)C=C1Cl NHJBORAJQCASEU-DGWZTRNLSA-N 0.000 claims description 2
- ASMNWZNWKPJLKW-RUZDIDTESA-N (3r)-3-[2-[2-benzyl-6-(1,3-dioxolan-2-ylmethoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC(C(=N1)CC=2C=CC=CC=2)=CC=C1OCC1OCCO1 ASMNWZNWKPJLKW-RUZDIDTESA-N 0.000 claims description 2
- UZHHSIMVEBGQQF-AREMUKBSSA-N (3r)-3-[2-[2-benzyl-6-(1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC1=CC=C(N2CC3(CC2)OCCO3)N=C1CC1=CC=CC=C1 UZHHSIMVEBGQQF-AREMUKBSSA-N 0.000 claims description 2
- NWVMIZSSUUXDDV-XMMPIXPASA-N (3r)-3-[2-[2-benzyl-6-(2-methoxyethoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(OCCOC)=CC=C(C#C[C@]2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 NWVMIZSSUUXDDV-XMMPIXPASA-N 0.000 claims description 2
- ZPLWMOWTDZXWFP-XMMPIXPASA-N (3r)-3-[2-[2-benzyl-6-(3-fluoropropoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC1=CC=C(OCCCF)N=C1CC1=CC=CC=C1 ZPLWMOWTDZXWFP-XMMPIXPASA-N 0.000 claims description 2
- CRCYUEWYLQPERX-XMMPIXPASA-N (3r)-3-[2-[2-benzyl-6-(3-hydroxypropoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(OCCCO)=CC=C(C#C[C@]2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 CRCYUEWYLQPERX-XMMPIXPASA-N 0.000 claims description 2
- HVIKCINYHLGLMN-RUZDIDTESA-N (3r)-3-[2-[2-benzyl-6-(3-methoxypropoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(OCCCOC)=CC=C(C#C[C@]2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 HVIKCINYHLGLMN-RUZDIDTESA-N 0.000 claims description 2
- OODSBPGFEGSHHP-RGSZASNESA-N (3r)-3-[2-[2-benzyl-6-[(3r,4r)-3,4-dimethoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@@H](OC)[C@H](OC)CN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 OODSBPGFEGSHHP-RGSZASNESA-N 0.000 claims description 2
- OODSBPGFEGSHHP-CMTIAEDTSA-N (3r)-3-[2-[2-benzyl-6-[(3s,4r)-3,4-dimethoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@H](OC)[C@H](OC)CN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 OODSBPGFEGSHHP-CMTIAEDTSA-N 0.000 claims description 2
- NPNDZGDIYBQJBA-GGBSJPMNSA-N (3r)-3-[2-[2-benzyl-6-[(3s,4r)-3-fluoro-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@H](F)[C@H](OC)CN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 NPNDZGDIYBQJBA-GGBSJPMNSA-N 0.000 claims description 2
- XBLZPMUGKVSXBK-MUUNZHRXSA-N (3r)-3-[2-[6-(1,3-benzodioxol-5-yl)-4-benzylpyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC1=CN=C(C=2C=C3OCOC3=CC=2)C=C1CC1=CC=CC=C1 XBLZPMUGKVSXBK-MUUNZHRXSA-N 0.000 claims description 2
- NIICMDFQAAQYJV-RJIQGDMUSA-N (3r)-3-[2-[6-benzyl-2-[(3r,4r)-3-hydroxy-4-methoxypyrrolidin-1-yl]-2h-pyrimidin-1-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@@H](O)[C@H](OC)CN1C1N(C#C[C@]2(O)C3CCN(CC3)C2)C(CC=2C=CC=CC=2)=CC=N1 NIICMDFQAAQYJV-RJIQGDMUSA-N 0.000 claims description 2
- MLSXUPJQSFAOJQ-DFZDUAMZSA-N (3r,4r)-1-[6-benzyl-5-[2-[(3r)-3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl]ethynyl]pyridin-2-yl]-3,4-dimethoxypyrrolidin-2-one Chemical compound O=C1[C@H](OC)[C@H](OC)CN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 MLSXUPJQSFAOJQ-DFZDUAMZSA-N 0.000 claims description 2
- GHHFZBBAFYHWMP-QIGHUWCUSA-N (3r,4r)-1-[6-benzyl-5-[2-[(3r)-3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl]ethynyl]pyridin-2-yl]-4-hydroxy-3-methoxypyrrolidin-2-one Chemical compound O=C1[C@H](OC)[C@H](O)CN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 GHHFZBBAFYHWMP-QIGHUWCUSA-N 0.000 claims description 2
- HVIKCINYHLGLMN-VWLOTQADSA-N (3s)-3-[2-[2-benzyl-6-(3-methoxypropoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(OCCCOC)=CC=C(C#C[C@@]2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 HVIKCINYHLGLMN-VWLOTQADSA-N 0.000 claims description 2
- KHYCPUINEHJEPG-UHFFFAOYSA-N 3-[2-(2-benzyl-6-pyridin-2-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CC=C(C=2N=CC=CC=2)N=C1CC1=CC=CC=C1 KHYCPUINEHJEPG-UHFFFAOYSA-N 0.000 claims description 2
- TXUOULDIWREEEA-UHFFFAOYSA-N 3-[2-(2-benzyl-6-pyridin-4-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CC=C(C=2C=CN=CC=2)N=C1CC1=CC=CC=C1 TXUOULDIWREEEA-UHFFFAOYSA-N 0.000 claims description 2
- GGVWDUVFTMWMAZ-UHFFFAOYSA-N 3-[2-(3-benzyl-5-pyridin-2-ylpyridin-2-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=NC=C(C=2N=CC=CC=2)C=C1CC1=CC=CC=C1 GGVWDUVFTMWMAZ-UHFFFAOYSA-N 0.000 claims description 2
- VTDXMTCJTBOGPE-UHFFFAOYSA-N 3-[2-(3-benzyl-5-pyridin-3-ylpyridin-2-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=NC=C(C=2C=NC=CC=2)C=C1CC1=CC=CC=C1 VTDXMTCJTBOGPE-UHFFFAOYSA-N 0.000 claims description 2
- SWRWIZVKWSUQRG-UHFFFAOYSA-N 3-[2-(3-benzyl-5-pyridin-4-ylpyridin-2-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=NC=C(C=2C=CN=CC=2)C=C1CC1=CC=CC=C1 SWRWIZVKWSUQRG-UHFFFAOYSA-N 0.000 claims description 2
- QRCWIJZKLBMEAT-UHFFFAOYSA-N 3-[2-(4-benzyl-2-pyridin-2-ylpyrimidin-5-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2N=CC=CC=2)N=C1CC1=CC=CC=C1 QRCWIJZKLBMEAT-UHFFFAOYSA-N 0.000 claims description 2
- WEMVGIPETQGIBZ-UHFFFAOYSA-N 3-[2-(4-benzyl-2-pyridin-3-ylpyrimidin-5-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2C=NC=CC=2)N=C1CC1=CC=CC=C1 WEMVGIPETQGIBZ-UHFFFAOYSA-N 0.000 claims description 2
- NPQXECSOLBQJBZ-UHFFFAOYSA-N 3-[2-(4-benzyl-6-pyridin-2-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2N=CC=CC=2)C=C1CC1=CC=CC=C1 NPQXECSOLBQJBZ-UHFFFAOYSA-N 0.000 claims description 2
- NQHGFEKZZYGIFD-UHFFFAOYSA-N 3-[2-(4-benzyl-6-pyridin-3-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2C=NC=CC=2)C=C1CC1=CC=CC=C1 NQHGFEKZZYGIFD-UHFFFAOYSA-N 0.000 claims description 2
- VIYULUBSFJIRSS-UHFFFAOYSA-N 3-[2-(4-benzyl-6-pyridin-4-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2C=CN=CC=2)C=C1CC1=CC=CC=C1 VIYULUBSFJIRSS-UHFFFAOYSA-N 0.000 claims description 2
- NSTBTVIRONZDIG-UHFFFAOYSA-N 3-[2-[2-(1,3-benzodioxol-5-yl)-4-benzylpyrimidin-5-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2C=C3OCOC3=CC=2)N=C1CC1=CC=CC=C1 NSTBTVIRONZDIG-UHFFFAOYSA-N 0.000 claims description 2
- NWVMIZSSUUXDDV-UHFFFAOYSA-N 3-[2-[2-benzyl-6-(2-methoxyethoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(OCCOC)=CC=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 NWVMIZSSUUXDDV-UHFFFAOYSA-N 0.000 claims description 2
- OAYXEWZCXZUBDL-UHFFFAOYSA-N 3-[2-[2-benzyl-6-(3-methoxypropylamino)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(NCCCOC)=CC=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 OAYXEWZCXZUBDL-UHFFFAOYSA-N 0.000 claims description 2
- KXTISGSEJHHJDM-UHFFFAOYSA-N 3-[2-[2-benzyl-6-(4-methoxypiperidin-1-yl)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CC(OC)CCN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#CC1(O)C(CC2)CCN2C1 KXTISGSEJHHJDM-UHFFFAOYSA-N 0.000 claims description 2
- ICNOVGPWMZQQDX-UHFFFAOYSA-N 3-[2-[3-benzyl-5-(3-hydroxybutyl)pyridin-2-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C=1C(CCC(O)C)=CN=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 ICNOVGPWMZQQDX-UHFFFAOYSA-N 0.000 claims description 2
- ZXLMGLFTKVRDQB-UHFFFAOYSA-N 3-[2-[4-benzyl-6-(2-methoxyethoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC=1C=NC(OCCOC)=CC=1CC1=CC=CC=C1 ZXLMGLFTKVRDQB-UHFFFAOYSA-N 0.000 claims description 2
- XBLZPMUGKVSXBK-UHFFFAOYSA-N 3-[2-[6-(1,3-benzodioxol-5-yl)-4-benzylpyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CN=C(C=2C=C3OCOC3=CC=2)C=C1CC1=CC=CC=C1 XBLZPMUGKVSXBK-UHFFFAOYSA-N 0.000 claims description 2
- ZCFZYSCFHRLMDM-SZGIACGNSA-N 3-[6-benzyl-5-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]pyridin-2-yl]oxypropyl (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound N=1C(OCCCOC(=O)[C@@H](NC(=O)OC(C)(C)C)C)=CC=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 ZCFZYSCFHRLMDM-SZGIACGNSA-N 0.000 claims description 2
- XFLRNLFYAVASJD-UHFFFAOYSA-N 4-[5-benzyl-6-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]pyridin-3-yl]butan-2-one Chemical compound C=1C(CCC(=O)C)=CN=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 XFLRNLFYAVASJD-UHFFFAOYSA-N 0.000 claims description 2
- AJHSLZXRMVVIFM-UHFFFAOYSA-N 4-o-[3-[6-benzyl-5-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]pyridin-2-yl]oxypropyl] 1-o-methyl butanedioate Chemical compound N=1C(OCCCOC(=O)CCC(=O)OC)=CC=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 AJHSLZXRMVVIFM-UHFFFAOYSA-N 0.000 claims description 2
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 2
- 150000001555 benzenes Chemical class 0.000 claims description 2
- YYIYZXJBNNVZAD-UHFFFAOYSA-N ethyl 1-[6-benzyl-5-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]pyridin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#CC1(O)C(CC2)CCN2C1 YYIYZXJBNNVZAD-UHFFFAOYSA-N 0.000 claims description 2
- RXGKPHWPUCOBRB-UHFFFAOYSA-N ethyl 3-[5-benzyl-6-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]pyridin-3-yl]propanoate Chemical compound C=1C(CCC(=O)OCC)=CN=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 RXGKPHWPUCOBRB-UHFFFAOYSA-N 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims 3
- HVIKCINYHLGLMN-UHFFFAOYSA-N 3-[2-[2-benzyl-6-(3-methoxypropoxy)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(OCCCOC)=CC=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 HVIKCINYHLGLMN-UHFFFAOYSA-N 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract description 14
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 abstract description 12
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 abstract description 12
- 229940031439 squalene Drugs 0.000 abstract description 12
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 abstract description 12
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 9
- 230000002194 synthesizing effect Effects 0.000 abstract description 5
- 229910052717 sulfur Inorganic materials 0.000 abstract description 3
- 125000003118 aryl group Chemical group 0.000 abstract description 2
- 229940125532 enzyme inhibitor Drugs 0.000 abstract description 2
- 239000002532 enzyme inhibitor Substances 0.000 abstract description 2
- 125000004434 sulfur atom Chemical group 0.000 abstract description 2
- 125000006591 (C2-C6) alkynylene group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 899
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 519
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 286
- 239000000203 mixture Substances 0.000 description 276
- 238000005160 1H NMR spectroscopy Methods 0.000 description 257
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 228
- 239000000243 solution Substances 0.000 description 222
- 238000003756 stirring Methods 0.000 description 210
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 194
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 181
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 179
- 239000002904 solvent Substances 0.000 description 164
- 101150041968 CDC13 gene Proteins 0.000 description 156
- 238000010898 silica gel chromatography Methods 0.000 description 124
- 239000012267 brine Substances 0.000 description 121
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 121
- 239000012074 organic phase Substances 0.000 description 119
- 238000006243 chemical reaction Methods 0.000 description 116
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 108
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 107
- 238000001816 cooling Methods 0.000 description 105
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 95
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 86
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 73
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 72
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 58
- 239000000741 silica gel Substances 0.000 description 57
- 229910002027 silica gel Inorganic materials 0.000 description 57
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 55
- 239000012299 nitrogen atmosphere Substances 0.000 description 54
- 239000003921 oil Substances 0.000 description 54
- 235000019198 oils Nutrition 0.000 description 54
- 238000010438 heat treatment Methods 0.000 description 46
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 36
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 35
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 35
- 229940107161 cholesterol Drugs 0.000 description 35
- 235000012000 cholesterol Nutrition 0.000 description 34
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 31
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- 230000015572 biosynthetic process Effects 0.000 description 27
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 26
- YRTHQTAVIFQEEG-UHFFFAOYSA-N 3-ethynyl-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CC2C(O)(C#C)CN1CC2 YRTHQTAVIFQEEG-UHFFFAOYSA-N 0.000 description 24
- 238000004519 manufacturing process Methods 0.000 description 24
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- 235000010724 Wisteria floribunda Nutrition 0.000 description 19
- 239000003480 eluent Substances 0.000 description 19
- 238000010992 reflux Methods 0.000 description 19
- 238000000926 separation method Methods 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000004440 column chromatography Methods 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 18
- 230000002401 inhibitory effect Effects 0.000 description 18
- 239000011780 sodium chloride Substances 0.000 description 18
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 17
- 239000013078 crystal Substances 0.000 description 17
- 238000000746 purification Methods 0.000 description 17
- DIOHEXPTUTVCNX-UHFFFAOYSA-N 1,1,1-trifluoro-n-phenyl-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)N(S(=O)(=O)C(F)(F)F)C1=CC=CC=C1 DIOHEXPTUTVCNX-UHFFFAOYSA-N 0.000 description 16
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 16
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 16
- 238000001914 filtration Methods 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 15
- 239000012312 sodium hydride Substances 0.000 description 15
- 229910000104 sodium hydride Inorganic materials 0.000 description 15
- YRTHQTAVIFQEEG-SECBINFHSA-N (3r)-3-ethynyl-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CC2[C@@](O)(C#C)CN1CC2 YRTHQTAVIFQEEG-SECBINFHSA-N 0.000 description 14
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 14
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 14
- 238000005481 NMR spectroscopy Methods 0.000 description 14
- 229910021529 ammonia Inorganic materials 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 229910000027 potassium carbonate Inorganic materials 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- 239000012298 atmosphere Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 11
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 11
- 239000008096 xylene Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 239000003112 inhibitor Substances 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 8
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 8
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 8
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 8
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 7
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 7
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 7
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 7
- 235000019345 sodium thiosulphate Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- RXPKSMCFASMGIO-UHFFFAOYSA-N (6-benzyl-5-bromopyridin-2-yl) trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=C(Br)C(CC=2C=CC=CC=2)=N1 RXPKSMCFASMGIO-UHFFFAOYSA-N 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidine Chemical compound CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 6
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- GCTFWCDSFPMHHS-UHFFFAOYSA-M Tributyltin chloride Chemical compound CCCC[Sn](Cl)(CCCC)CCCC GCTFWCDSFPMHHS-UHFFFAOYSA-M 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 235000019270 ammonium chloride Nutrition 0.000 description 6
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000002198 insoluble material Substances 0.000 description 6
- 210000005229 liver cell Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- SDIGCJPJDADGQP-HZPDHXFCSA-N (3r,4r)-1-(6-benzyl-5-iodopyridin-2-yl)-4-methoxypyrrolidin-3-ol Chemical compound C1[C@@H](O)[C@H](OC)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 SDIGCJPJDADGQP-HZPDHXFCSA-N 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 5
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 125000001309 chloro group Chemical group Cl* 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 235000010265 sodium sulphite Nutrition 0.000 description 5
- KQQWMDCMXOEVAD-HUUCEWRRSA-N (3r,4r)-1-(6-benzylpyridin-2-yl)pyrrolidine-3,4-diol Chemical compound C1[C@@H](O)[C@H](O)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 KQQWMDCMXOEVAD-HUUCEWRRSA-N 0.000 description 4
- DYDWNBBKGYZVAT-UHFFFAOYSA-N (6-benzylpyridin-2-yl) trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=CC(CC=2C=CC=CC=2)=N1 DYDWNBBKGYZVAT-UHFFFAOYSA-N 0.000 description 4
- FEYDZHNIIMENOB-UHFFFAOYSA-N 2,6-dibromopyridine Chemical compound BrC1=CC=CC(Br)=N1 FEYDZHNIIMENOB-UHFFFAOYSA-N 0.000 description 4
- AGCVUKAOFJIRET-UHFFFAOYSA-N 2-benzyl-6-iodo-3-(methoxymethoxy)pyridine Chemical compound COCOC1=CC=C(I)N=C1CC1=CC=CC=C1 AGCVUKAOFJIRET-UHFFFAOYSA-N 0.000 description 4
- KFRXXEQMQORHHI-UHFFFAOYSA-N 3-[2-(3-benzyl-5-bromopyridin-2-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=NC=C(Br)C=C1CC1=CC=CC=C1 KFRXXEQMQORHHI-UHFFFAOYSA-N 0.000 description 4
- CAGIGIIODKPWGE-UHFFFAOYSA-N 3-benzyl-5-bromo-2-methoxypyridine Chemical compound COC1=NC=C(Br)C=C1CC1=CC=CC=C1 CAGIGIIODKPWGE-UHFFFAOYSA-N 0.000 description 4
- XRBYIEYRAFPGQH-UHFFFAOYSA-N 5-benzyl-6-methoxypyridine-3-carboxylic acid Chemical compound COC1=NC=C(C(O)=O)C=C1CC1=CC=CC=C1 XRBYIEYRAFPGQH-UHFFFAOYSA-N 0.000 description 4
- RTDFZXXNVMMFAD-UHFFFAOYSA-N 6-benzyl-5-bromo-1h-pyridin-2-one Chemical compound OC1=CC=C(Br)C(CC=2C=CC=CC=2)=N1 RTDFZXXNVMMFAD-UHFFFAOYSA-N 0.000 description 4
- AFBIDOLMRSQGRO-UHFFFAOYSA-N 6-methyl-2-(2-phenylethenyl)-3-phenylmethoxypyridine Chemical compound C=1C=CC=CC=1C=CC1=NC(C)=CC=C1OCC1=CC=CC=C1 AFBIDOLMRSQGRO-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 239000000370 acceptor Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- ZBQUMMFUJLOTQC-UHFFFAOYSA-N dichloronickel;3-diphenylphosphaniumylpropyl(diphenyl)phosphanium Chemical compound Cl[Ni]Cl.C=1C=CC=CC=1[PH+](C=1C=CC=CC=1)CCC[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 ZBQUMMFUJLOTQC-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 4
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 4
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000001853 liver microsome Anatomy 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 4
- LFXHSPHHJJRZNA-UHFFFAOYSA-N (2-bromo-6-iodopyridin-3-yl) trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=C(I)N=C1Br LFXHSPHHJJRZNA-UHFFFAOYSA-N 0.000 description 3
- KDNPGUUWHZBRKB-UHFFFAOYSA-N (2-chloropyridin-4-yl)-phenylmethanone Chemical compound C1=NC(Cl)=CC(C(=O)C=2C=CC=CC=2)=C1 KDNPGUUWHZBRKB-UHFFFAOYSA-N 0.000 description 3
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 3
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 3
- NDEOTZXSBKCQLS-DGWZTRNLSA-N (3r)-3-[2-[2-benzyl-6-[(3r,4r)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@@H](O)[C@H](OC)CN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 NDEOTZXSBKCQLS-DGWZTRNLSA-N 0.000 description 3
- LICHZHNJSHAUKQ-RKDXNWHRSA-N (3r,4r)-1-(6-bromopyridin-2-yl)-4-(methoxymethoxy)pyrrolidin-3-ol Chemical compound C1[C@@H](O)[C@H](OCOC)CN1C1=CC=CC(Br)=N1 LICHZHNJSHAUKQ-RKDXNWHRSA-N 0.000 description 3
- FPNGSMMQGNCWFS-UHFFFAOYSA-N (4-benzyl-5-bromopyridin-2-yl) trifluoromethanesulfonate Chemical compound C1=NC(OS(=O)(=O)C(F)(F)F)=CC(CC=2C=CC=CC=2)=C1Br FPNGSMMQGNCWFS-UHFFFAOYSA-N 0.000 description 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 3
- UWGZNXOPOQZWLU-UHFFFAOYSA-N 2-benzyl-6-(4-hydroxyoxan-4-yl)pyridin-3-ol Chemical compound OC1=CC=C(C2(O)CCOCC2)N=C1CC1=CC=CC=C1 UWGZNXOPOQZWLU-UHFFFAOYSA-N 0.000 description 3
- ODWNSGVEPMJYSN-DLBZAZTESA-N 2-benzyl-6-[(3r,4s)-3-(fluoromethoxy)-4-methoxypyrrolidin-1-yl]pyridine Chemical compound C1[C@@H](OCF)[C@@H](OC)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 ODWNSGVEPMJYSN-DLBZAZTESA-N 0.000 description 3
- PUEAMUBDFAAVEE-UHFFFAOYSA-N 2-benzyl-6-methoxypyridine Chemical compound COC1=CC=CC(CC=2C=CC=CC=2)=N1 PUEAMUBDFAAVEE-UHFFFAOYSA-N 0.000 description 3
- GELVZYOEQVJIRR-UHFFFAOYSA-N 2-chloropyrazine Chemical compound ClC1=CN=CC=N1 GELVZYOEQVJIRR-UHFFFAOYSA-N 0.000 description 3
- APKABZVBYAUJOF-UHFFFAOYSA-N 2-ethynyl-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CN2CCC1C(O)C2C#C APKABZVBYAUJOF-UHFFFAOYSA-N 0.000 description 3
- RCGFRLCJCFDVOQ-UHFFFAOYSA-N 4-(6-bromopyridin-2-yl)morpholine Chemical compound BrC1=CC=CC(N2CCOCC2)=N1 RCGFRLCJCFDVOQ-UHFFFAOYSA-N 0.000 description 3
- YUBPWOAHTNMVPI-UHFFFAOYSA-N 4-[6-benzyl-5-(methoxymethoxy)pyridin-2-yl]oxan-4-ol Chemical compound COCOC1=CC=C(C2(O)CCOCC2)N=C1CC1=CC=CC=C1 YUBPWOAHTNMVPI-UHFFFAOYSA-N 0.000 description 3
- DVSWXYFVLSXDCS-UHFFFAOYSA-N 4-benzyl-5-bromo-2-iodopyrimidine Chemical compound BrC1=CN=C(I)N=C1CC1=CC=CC=C1 DVSWXYFVLSXDCS-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229940043259 farnesol Drugs 0.000 description 3
- 229930002886 farnesol Natural products 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 3
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- BOABLMHZQMXLBD-UHFFFAOYSA-N (2-chloropyridin-3-yl)-thiophen-2-ylmethanone Chemical compound ClC1=NC=CC=C1C(=O)C1=CC=CS1 BOABLMHZQMXLBD-UHFFFAOYSA-N 0.000 description 2
- DKODHPMXNSZZJH-UHFFFAOYSA-N (2-methoxy-6-tributylstannylpyridin-3-yl)-phenylmethanone Chemical compound COC1=NC([Sn](CCCC)(CCCC)CCCC)=CC=C1C(=O)C1=CC=CC=C1 DKODHPMXNSZZJH-UHFFFAOYSA-N 0.000 description 2
- LAEUNQSEPMMGIM-UHFFFAOYSA-N (2-methoxypyridin-3-yl)-thiophen-2-ylmethanone Chemical compound COC1=NC=CC=C1C(=O)C1=CC=CS1 LAEUNQSEPMMGIM-UHFFFAOYSA-N 0.000 description 2
- ZQSGLJSAHLZOMO-UHFFFAOYSA-N (2-methoxypyridin-4-yl)-phenylmethanone Chemical compound C1=NC(OC)=CC(C(=O)C=2C=CC=CC=2)=C1 ZQSGLJSAHLZOMO-UHFFFAOYSA-N 0.000 description 2
- XHKOKAUUWXVGKG-UHFFFAOYSA-N (5-benzoyl-6-methoxypyridin-2-yl)methyl acetate Chemical compound COC1=NC(COC(C)=O)=CC=C1C(=O)C1=CC=CC=C1 XHKOKAUUWXVGKG-UHFFFAOYSA-N 0.000 description 2
- XTVDWRHELZEWLB-UHFFFAOYSA-N (6-chloro-2-methoxypyridin-3-yl)-phenylmethanone Chemical compound COC1=NC(Cl)=CC=C1C(=O)C1=CC=CC=C1 XTVDWRHELZEWLB-UHFFFAOYSA-N 0.000 description 2
- MWVSUOBZYMYAPW-UHFFFAOYSA-N (6-methyl-3-phenylmethoxypyridin-2-yl)-phenylmethanol Chemical compound C=1C=CC=CC=1C(O)C1=NC(C)=CC=C1OCC1=CC=CC=C1 MWVSUOBZYMYAPW-UHFFFAOYSA-N 0.000 description 2
- KZLPIUDCNJSSJD-UHFFFAOYSA-N (6-methyl-3-phenylmethoxypyridin-2-yl)-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1=NC(C)=CC=C1OCC1=CC=CC=C1 KZLPIUDCNJSSJD-UHFFFAOYSA-N 0.000 description 2
- VTFUMBATUAVGOW-UHFFFAOYSA-N (6-methyl-3-phenylmethoxypyridin-2-yl)methanol Chemical compound OCC1=NC(C)=CC=C1OCC1=CC=CC=C1 VTFUMBATUAVGOW-UHFFFAOYSA-N 0.000 description 2
- UFUZYPWYOKMSOM-UHFFFAOYSA-N 1,3-benzodioxol-5-yl(tributyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=C2OCOC2=C1 UFUZYPWYOKMSOM-UHFFFAOYSA-N 0.000 description 2
- BOSOITABFLMIFZ-UHFFFAOYSA-N 1-(6-benzyl-5-hydroxypyridin-2-yl)cyclohexane-1,4-diol Chemical compound C1CC(O)CCC1(O)C1=CC=C(O)C(CC=2C=CC=CC=2)=N1 BOSOITABFLMIFZ-UHFFFAOYSA-N 0.000 description 2
- WWHTZWXAZJJPRA-UHFFFAOYSA-N 1-(6-bromopyridin-2-yl)pyrrolidin-3-ol Chemical compound C1C(O)CCN1C1=CC=CC(Br)=N1 WWHTZWXAZJJPRA-UHFFFAOYSA-N 0.000 description 2
- KGARCSYHUWHUMQ-UHFFFAOYSA-N 1-iodo-2-(methoxymethoxy)benzene Chemical compound COCOC1=CC=CC=C1I KGARCSYHUWHUMQ-UHFFFAOYSA-N 0.000 description 2
- WBPLEIZTTNUEHT-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-4-benzyl-5-bromopyridine Chemical compound BrC1=CN=C(C=2C=C3OCOC3=CC=2)C=C1CC1=CC=CC=C1 WBPLEIZTTNUEHT-UHFFFAOYSA-N 0.000 description 2
- WXSZSJQELPFSHK-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methyl]-6-methylpyridin-3-ol Chemical compound C1=CC(OC)=CC=C1CC1=NC(C)=CC=C1O WXSZSJQELPFSHK-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- DHPIDKOMGBVHNA-UHFFFAOYSA-N 2-benzyl-3-(methoxymethoxy)pyridine Chemical compound COCOC1=CC=CN=C1CC1=CC=CC=C1 DHPIDKOMGBVHNA-UHFFFAOYSA-N 0.000 description 2
- DYBZXTMOZILFCH-UHFFFAOYSA-N 2-benzyl-3-bromo-6-(2-methoxyethoxy)pyridine Chemical compound COCCOC1=CC=C(Br)C(CC=2C=CC=CC=2)=N1 DYBZXTMOZILFCH-UHFFFAOYSA-N 0.000 description 2
- YVUZHYZWTPVBRF-UHFFFAOYSA-N 2-benzyl-3-bromo-6-(3-methoxyprop-1-ynyl)pyridine Chemical compound COCC#CC1=CC=C(Br)C(CC=2C=CC=CC=2)=N1 YVUZHYZWTPVBRF-UHFFFAOYSA-N 0.000 description 2
- ASBGRUMICTWDLT-UHFFFAOYSA-N 2-benzyl-3-bromo-6-methoxypyridine Chemical compound COC1=CC=C(Br)C(CC=2C=CC=CC=2)=N1 ASBGRUMICTWDLT-UHFFFAOYSA-N 0.000 description 2
- CWBFZHINCCWHST-UHFFFAOYSA-N 2-benzyl-3-bromo-6-pyridin-4-ylpyridine Chemical compound BrC1=CC=C(C=2C=CN=CC=2)N=C1CC1=CC=CC=C1 CWBFZHINCCWHST-UHFFFAOYSA-N 0.000 description 2
- VFJILQFXTITAJH-UHFFFAOYSA-N 2-benzyl-6-(2-hydroxyphenyl)pyridin-3-ol Chemical compound OC1=CC=C(C=2C(=CC=CC=2)O)N=C1CC1=CC=CC=C1 VFJILQFXTITAJH-UHFFFAOYSA-N 0.000 description 2
- BBCDNJLWDOFWAM-DLBZAZTESA-N 2-benzyl-6-[(3s,4r)-3-fluoro-4-(methoxymethoxy)pyrrolidin-1-yl]pyridine Chemical compound C1[C@H](F)[C@H](OCOC)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 BBCDNJLWDOFWAM-DLBZAZTESA-N 0.000 description 2
- LLSXHJUFGZVESS-UHFFFAOYSA-N 2-benzyl-6-[[tert-butyl(dimethyl)silyl]oxymethyl]pyridin-3-ol Chemical compound CC(C)(C)[Si](C)(C)OCC1=CC=C(O)C(CC=2C=CC=CC=2)=N1 LLSXHJUFGZVESS-UHFFFAOYSA-N 0.000 description 2
- IRPCCIFUYYGBAE-UHFFFAOYSA-N 2-benzyl-6-iodopyridin-3-ol Chemical compound OC1=CC=C(I)N=C1CC1=CC=CC=C1 IRPCCIFUYYGBAE-UHFFFAOYSA-N 0.000 description 2
- CATUEJFGWSUPBV-UHFFFAOYSA-N 2-bromo-3-(methoxymethoxy)pyridine Chemical compound COCOC1=CC=CN=C1Br CATUEJFGWSUPBV-UHFFFAOYSA-N 0.000 description 2
- IQUADFAYJOJQJA-UHFFFAOYSA-N 2-bromo-6-iodopyridin-3-ol Chemical compound OC1=CC=C(I)N=C1Br IQUADFAYJOJQJA-UHFFFAOYSA-N 0.000 description 2
- KMODISUYWZPVGV-UHFFFAOYSA-N 2-bromo-6-methoxypyridine Chemical compound COC1=CC=CC(Br)=N1 KMODISUYWZPVGV-UHFFFAOYSA-N 0.000 description 2
- YKHQFTANTNMYPP-UHFFFAOYSA-N 2-bromopyridin-3-ol Chemical compound OC1=CC=CN=C1Br YKHQFTANTNMYPP-UHFFFAOYSA-N 0.000 description 2
- IBRSSZOHCGUTHI-UHFFFAOYSA-N 2-chloropyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1Cl IBRSSZOHCGUTHI-UHFFFAOYSA-N 0.000 description 2
- VPSGDHZFVJANQC-UHFFFAOYSA-N 2-iodo-1,3,4-thiadiazole Chemical compound IC1=NN=CS1 VPSGDHZFVJANQC-UHFFFAOYSA-N 0.000 description 2
- OHXAOPZTJOUYKM-UHFFFAOYSA-N 3-Chloro-2-methylpropene Chemical compound CC(=C)CCl OHXAOPZTJOUYKM-UHFFFAOYSA-N 0.000 description 2
- CMABPRGEEVDCPP-UHFFFAOYSA-N 3-[2-(6-morpholin-4-yl-2-phenoxypyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CC=C(N2CCOCC2)N=C1OC1=CC=CC=C1 CMABPRGEEVDCPP-UHFFFAOYSA-N 0.000 description 2
- OQRXXDHEMRUREE-UHFFFAOYSA-N 3-[2-(6-morpholin-4-yl-2-phenylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CC=C(N2CCOCC2)N=C1C1=CC=CC=C1 OQRXXDHEMRUREE-UHFFFAOYSA-N 0.000 description 2
- FNUMLDJSIZVSLJ-UHFFFAOYSA-N 3-[2-[6-methyl-2-(2-phenylethenyl)pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound N=1C(C)=CC=C(C#CC2(O)C3CCN(CC3)C2)C=1C=CC1=CC=CC=C1 FNUMLDJSIZVSLJ-UHFFFAOYSA-N 0.000 description 2
- SZBDEHQIVBUTPP-UHFFFAOYSA-N 3-[6-benzyl-5-(methoxymethoxy)pyridin-2-yl]propan-1-ol Chemical compound COCOC1=CC=C(CCCO)N=C1CC1=CC=CC=C1 SZBDEHQIVBUTPP-UHFFFAOYSA-N 0.000 description 2
- SXCVRDXQFIZSFR-UHFFFAOYSA-N 3-benzyl-2-methoxypyridine Chemical compound COC1=NC=CC=C1CC1=CC=CC=C1 SXCVRDXQFIZSFR-UHFFFAOYSA-N 0.000 description 2
- NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 2
- MWWNNNAOGWPTQY-UHFFFAOYSA-N 3-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(S(Cl)(=O)=O)=C1 MWWNNNAOGWPTQY-UHFFFAOYSA-N 0.000 description 2
- DUBPLDMZCBIVNC-UHFFFAOYSA-N 4-(5-iodo-6-phenylpyridin-2-yl)morpholine Chemical compound IC1=CC=C(N2CCOCC2)N=C1C1=CC=CC=C1 DUBPLDMZCBIVNC-UHFFFAOYSA-N 0.000 description 2
- GPJMEAFWJJLEAB-UHFFFAOYSA-N 4-(6-benzyl-5-hydroxypyridin-2-yl)-4-hydroxycyclohexan-1-one Chemical compound OC1=CC=C(C2(O)CCC(=O)CC2)N=C1CC1=CC=CC=C1 GPJMEAFWJJLEAB-UHFFFAOYSA-N 0.000 description 2
- GUUWRLBALIXDFK-UHFFFAOYSA-N 4-(6-phenylpyridin-2-yl)morpholine Chemical compound C1COCCN1C1=CC=CC(C=2C=CC=CC=2)=N1 GUUWRLBALIXDFK-UHFFFAOYSA-N 0.000 description 2
- PSZDNGZEEPBPAS-UHFFFAOYSA-N 4-[6-benzyl-5-(methoxymethoxy)pyridin-2-yl]-1-methoxybut-3-en-2-one Chemical compound COCOC1=CC=C(C=CC(=O)COC)N=C1CC1=CC=CC=C1 PSZDNGZEEPBPAS-UHFFFAOYSA-N 0.000 description 2
- MYGIGZIOMBNMIC-UHFFFAOYSA-N 4-[6-benzyl-5-(methoxymethoxy)pyridin-2-yl]-1-methoxybutan-2-one Chemical compound COCOC1=CC=C(CCC(=O)COC)N=C1CC1=CC=CC=C1 MYGIGZIOMBNMIC-UHFFFAOYSA-N 0.000 description 2
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 2
- WEMTZOYNHLYUKF-UHFFFAOYSA-N 4-benzyl-2-methoxypyridine Chemical compound C1=NC(OC)=CC(CC=2C=CC=CC=2)=C1 WEMTZOYNHLYUKF-UHFFFAOYSA-N 0.000 description 2
- QRXXXKFLYFKWAN-UHFFFAOYSA-N 4-benzyl-5-bromo-1h-pyridin-2-one Chemical compound C1=NC(O)=CC(CC=2C=CC=CC=2)=C1Br QRXXXKFLYFKWAN-UHFFFAOYSA-N 0.000 description 2
- WBIYEUIKPWAOFO-UHFFFAOYSA-N 4-benzyl-5-bromo-2-(2-methoxyethoxy)pyridine Chemical compound C1=NC(OCCOC)=CC(CC=2C=CC=CC=2)=C1Br WBIYEUIKPWAOFO-UHFFFAOYSA-N 0.000 description 2
- MZUYGPWRLZECIY-UHFFFAOYSA-N 4-benzyl-5-bromo-2-methoxypyridine Chemical compound C1=NC(OC)=CC(CC=2C=CC=CC=2)=C1Br MZUYGPWRLZECIY-UHFFFAOYSA-N 0.000 description 2
- WTXKTHIFTLJPFN-UHFFFAOYSA-N 4-benzyl-5-bromo-2-pyridin-3-ylpyrimidine Chemical compound BrC1=CN=C(C=2C=NC=CC=2)N=C1CC1=CC=CC=C1 WTXKTHIFTLJPFN-UHFFFAOYSA-N 0.000 description 2
- MXWFAFBPBMLSRT-UHFFFAOYSA-N 4-benzylpyrimidin-2-amine Chemical compound NC1=NC=CC(CC=2C=CC=CC=2)=N1 MXWFAFBPBMLSRT-UHFFFAOYSA-N 0.000 description 2
- AMXSKTPKHQNOER-UHFFFAOYSA-N 5-benzyl-6-methoxy-n-phenylpyridine-3-carboxamide Chemical compound COC1=NC=C(C(=O)NC=2C=CC=CC=2)C=C1CC1=CC=CC=C1 AMXSKTPKHQNOER-UHFFFAOYSA-N 0.000 description 2
- ZKSFRBCDWIDXDY-UHFFFAOYSA-N 5-benzyl-6-methoxypyridine-3-carbaldehyde Chemical compound COC1=NC=C(C=O)C=C1CC1=CC=CC=C1 ZKSFRBCDWIDXDY-UHFFFAOYSA-N 0.000 description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 2
- NEXYFEYISMLKMD-UHFFFAOYSA-N 6-benzyl-1h-pyridin-2-one Chemical compound OC1=CC=CC(CC=2C=CC=CC=2)=N1 NEXYFEYISMLKMD-UHFFFAOYSA-N 0.000 description 2
- XQUQTPFCPUQDGI-UHFFFAOYSA-N 6-methyl-2-(2-phenylethyl)pyridin-3-ol Chemical compound CC1=CC=C(O)C(CCC=2C=CC=CC=2)=N1 XQUQTPFCPUQDGI-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- YZSGRFBJFVRBKP-UHFFFAOYSA-N [2-[(4-methoxyphenyl)methyl]-6-methylpyridin-3-yl] trifluoromethanesulfonate Chemical compound C1=CC(OC)=CC=C1CC1=NC(C)=CC=C1OS(=O)(=O)C(F)(F)F YZSGRFBJFVRBKP-UHFFFAOYSA-N 0.000 description 2
- LNKQEXUONSUWHF-UHFFFAOYSA-N [2-benzyl-6-(2-hydroxyphenyl)pyridin-3-yl] trifluoromethanesulfonate Chemical compound OC1=CC=CC=C1C1=CC=C(OS(=O)(=O)C(F)(F)F)C(CC=2C=CC=CC=2)=N1 LNKQEXUONSUWHF-UHFFFAOYSA-N 0.000 description 2
- WKPRTPXVSKPCGV-UHFFFAOYSA-N [2-benzyl-6-(4-hydroxyoxan-4-yl)pyridin-3-yl] trifluoromethanesulfonate Chemical compound C=1C=C(OS(=O)(=O)C(F)(F)F)C(CC=2C=CC=CC=2)=NC=1C1(O)CCOCC1 WKPRTPXVSKPCGV-UHFFFAOYSA-N 0.000 description 2
- ONQJGVRTBPQUJA-UHFFFAOYSA-N [2-benzyl-6-(4-methoxy-3-oxobutyl)pyridin-3-yl] trifluoromethanesulfonate Chemical compound COCC(=O)CCC1=CC=C(OS(=O)(=O)C(F)(F)F)C(CC=2C=CC=CC=2)=N1 ONQJGVRTBPQUJA-UHFFFAOYSA-N 0.000 description 2
- HHBOZXNMNGOPNB-UHFFFAOYSA-N [3-(thiophen-2-ylmethyl)pyridin-2-yl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=NC=CC=C1CC1=CC=CS1 HHBOZXNMNGOPNB-UHFFFAOYSA-N 0.000 description 2
- RUJNAOXQHVHOEI-UHFFFAOYSA-N [3-benzyl-5-(phenylcarbamoyl)pyridin-2-yl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=NC=C(C(=O)NC=2C=CC=CC=2)C=C1CC1=CC=CC=C1 RUJNAOXQHVHOEI-UHFFFAOYSA-N 0.000 description 2
- IFZCQTCAIGDJEE-UHFFFAOYSA-N [6-(hydroxymethyl)-3-phenylmethoxypyridin-2-yl]-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1=NC(CO)=CC=C1OCC1=CC=CC=C1 IFZCQTCAIGDJEE-UHFFFAOYSA-N 0.000 description 2
- FECCDQFYOHFYBB-UHFFFAOYSA-N [6-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-phenylmethoxypyridin-2-yl]-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1=NC(CO[Si](C)(C)C(C)(C)C)=CC=C1OCC1=CC=CC=C1 FECCDQFYOHFYBB-UHFFFAOYSA-N 0.000 description 2
- AUGFHORRHBVRPQ-UHFFFAOYSA-N [6-benzyl-5-(methoxymethoxy)pyridin-2-yl]-tributylstannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=C(OCOC)C(CC=2C=CC=CC=2)=N1 AUGFHORRHBVRPQ-UHFFFAOYSA-N 0.000 description 2
- SDCZBIZSGKTTDK-UHFFFAOYSA-N [6-benzyl-5-(methoxymethoxy)pyridin-2-yl]methanol Chemical compound COCOC1=CC=C(CO)N=C1CC1=CC=CC=C1 SDCZBIZSGKTTDK-UHFFFAOYSA-N 0.000 description 2
- WITLVFZILACCLP-UHFFFAOYSA-N [6-methyl-2-(2-phenylethyl)pyridin-3-yl] trifluoromethanesulfonate Chemical compound CC1=CC=C(OS(=O)(=O)C(F)(F)F)C(CCC=2C=CC=CC=2)=N1 WITLVFZILACCLP-UHFFFAOYSA-N 0.000 description 2
- CHHWLJJTMVLAMK-VKKIDBQXSA-N acetic acid;(3r,4r)-pyrrolidine-3,4-diol Chemical compound CC(O)=O.O[C@@H]1CNC[C@H]1O CHHWLJJTMVLAMK-VKKIDBQXSA-N 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 206010000891 acute myocardial infarction Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000004517 catalytic hydrocracking Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- GMULGDYFELZXMM-UHFFFAOYSA-N ethyl 1-(6-benzyl-5-iodopyridin-2-yl)piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 GMULGDYFELZXMM-UHFFFAOYSA-N 0.000 description 2
- UKUMTBUCSOKVOW-UHFFFAOYSA-N ethyl 1-(6-benzylpyridin-2-yl)piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC=CC(CC=2C=CC=CC=2)=N1 UKUMTBUCSOKVOW-UHFFFAOYSA-N 0.000 description 2
- ACXQVWPMSBGFMI-UHFFFAOYSA-N ethyl 3-(5-benzyl-6-methoxypyridin-3-yl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CN=C(OC)C(CC=2C=CC=CC=2)=C1 ACXQVWPMSBGFMI-UHFFFAOYSA-N 0.000 description 2
- VQRLWDMXABCJPV-UHFFFAOYSA-N ethyl 3-(5-benzyl-6-methoxypyridin-3-yl)propanoate Chemical compound CCOC(=O)CCC1=CN=C(OC)C(CC=2C=CC=CC=2)=C1 VQRLWDMXABCJPV-UHFFFAOYSA-N 0.000 description 2
- DMXXZOZFDJATLK-UHFFFAOYSA-N ethyl 3-(5-benzyl-6-oxo-1h-pyridin-3-yl)propanoate Chemical compound CCOC(=O)CCC1=CN=C(O)C(CC=2C=CC=CC=2)=C1 DMXXZOZFDJATLK-UHFFFAOYSA-N 0.000 description 2
- KIUIBFRINKWDOS-UHFFFAOYSA-N ethyl 3-[5-benzyl-6-(trifluoromethylsulfonyloxy)pyridin-3-yl]propanoate Chemical compound CCOC(=O)CCC1=CN=C(OS(=O)(=O)C(F)(F)F)C(CC=2C=CC=CC=2)=C1 KIUIBFRINKWDOS-UHFFFAOYSA-N 0.000 description 2
- GREFKUDDZZEOTL-UHFFFAOYSA-N ethyl 3-[6-benzyl-5-(methoxymethoxy)pyridin-2-yl]prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(OCOC)C(CC=2C=CC=CC=2)=N1 GREFKUDDZZEOTL-UHFFFAOYSA-N 0.000 description 2
- LGFFYIQIYXCFAE-UHFFFAOYSA-N ethyl 3-[6-benzyl-5-(methoxymethoxy)pyridin-2-yl]propanoate Chemical compound CCOC(=O)CCC1=CC=C(OCOC)C(CC=2C=CC=CC=2)=N1 LGFFYIQIYXCFAE-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- JZSAEJINKNJPNT-UHFFFAOYSA-N methyl 5-benzyl-6-(trifluoromethylsulfonyloxy)pyridine-3-carboxylate Chemical compound COC(=O)C1=CN=C(OS(=O)(=O)C(F)(F)F)C(CC=2C=CC=CC=2)=C1 JZSAEJINKNJPNT-UHFFFAOYSA-N 0.000 description 2
- REXVMTYUDINWNA-UHFFFAOYSA-N methyl 5-benzyl-6-methoxypyridine-3-carboxylate Chemical compound COC(=O)C1=CN=C(OC)C(CC=2C=CC=CC=2)=C1 REXVMTYUDINWNA-UHFFFAOYSA-N 0.000 description 2
- AMCXGOMBQUTKBK-UHFFFAOYSA-N methyl 5-benzyl-6-oxo-1h-pyridine-3-carboxylate Chemical compound COC(=O)C1=CN=C(O)C(CC=2C=CC=CC=2)=C1 AMCXGOMBQUTKBK-UHFFFAOYSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- JMJRYTGVHCAYCT-UHFFFAOYSA-N oxan-4-one Chemical compound O=C1CCOCC1 JMJRYTGVHCAYCT-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- ITKNMNFPAORDQT-UHFFFAOYSA-N tert-butyl n-(5-benzyl-6-methoxypyridin-3-yl)-n-methylcarbamate Chemical compound COC1=NC=C(N(C)C(=O)OC(C)(C)C)C=C1CC1=CC=CC=C1 ITKNMNFPAORDQT-UHFFFAOYSA-N 0.000 description 2
- YFRORTGMHUREJS-UHFFFAOYSA-N tert-butyl n-(5-benzyl-6-methoxypyridin-3-yl)carbamate Chemical compound COC1=NC=C(NC(=O)OC(C)(C)C)C=C1CC1=CC=CC=C1 YFRORTGMHUREJS-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- GYUURHMITDQTRU-UHFFFAOYSA-N tributyl(pyridin-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CC=N1 GYUURHMITDQTRU-UHFFFAOYSA-N 0.000 description 2
- CFQJBWKKHCMCGJ-UHFFFAOYSA-N tributyl(pyridin-3-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CN=C1 CFQJBWKKHCMCGJ-UHFFFAOYSA-N 0.000 description 2
- UNEPXPMBVGDXGH-UHFFFAOYSA-N tributyl(pyridin-4-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=NC=C1 UNEPXPMBVGDXGH-UHFFFAOYSA-N 0.000 description 2
- WTFFOOAJSDVASL-UHFFFAOYSA-N tributyl(pyrimidin-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=NC=CC=N1 WTFFOOAJSDVASL-UHFFFAOYSA-N 0.000 description 2
- REDSKZBUUUQMSK-UHFFFAOYSA-N tributyltin Chemical compound CCCC[Sn](CCCC)CCCC.CCCC[Sn](CCCC)CCCC REDSKZBUUUQMSK-UHFFFAOYSA-N 0.000 description 2
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 2
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 229940117972 triolein Drugs 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- HTIVCVIMTPICDE-UHFFFAOYSA-N (2-methoxy-6-methylpyridin-3-yl)-phenylmethanone Chemical compound COC1=NC(C)=CC=C1C(=O)C1=CC=CC=C1 HTIVCVIMTPICDE-UHFFFAOYSA-N 0.000 description 1
- YPNWJCXSAOEYFY-UHFFFAOYSA-N (2-methoxypyridin-3-yl)-thiophen-2-ylmethanol Chemical compound COC1=NC=CC=C1C(O)C1=CC=CS1 YPNWJCXSAOEYFY-UHFFFAOYSA-N 0.000 description 1
- HWZOPHAMCWZKFR-UHFFFAOYSA-N (2-methoxypyridin-4-yl)-phenylmethanol Chemical compound C1=NC(OC)=CC(C(O)C=2C=CC=CC=2)=C1 HWZOPHAMCWZKFR-UHFFFAOYSA-N 0.000 description 1
- WGUKWKJCWRPHOU-KZKMUFAMSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;(3r)-3-ethynyl-1-azabicyclo[2.2.2]octan-3-ol Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1CC2[C@@](O)(C#C)CN1CC2 WGUKWKJCWRPHOU-KZKMUFAMSA-N 0.000 description 1
- MFOKGLABTYIRDP-UHFFFAOYSA-N (3-benzyl-5-bromopyridin-2-yl) trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=NC=C(Br)C=C1CC1=CC=CC=C1 MFOKGLABTYIRDP-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- YQMXOIAIYXXXEE-LLVKDONJSA-N (3r)-1-benzylpyrrolidin-3-ol Chemical compound C1[C@H](O)CCN1CC1=CC=CC=C1 YQMXOIAIYXXXEE-LLVKDONJSA-N 0.000 description 1
- NDEOTZXSBKCQLS-RMTZWNOUSA-N (3r)-3-[2-[2-benzyl-6-[(3r,4s)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1[C@@H](O)[C@@H](OC)CN1C(N=C1CC=2C=CC=CC=2)=CC=C1C#C[C@]1(O)C(CC2)CCN2C1 NDEOTZXSBKCQLS-RMTZWNOUSA-N 0.000 description 1
- PHCXYSFEITYKCD-HZPDHXFCSA-N (3r,4r)-1-(6-benzyl-3-chloro-5-iodopyridin-2-yl)-4-methoxypyrrolidin-3-ol Chemical compound C1[C@@H](O)[C@H](OC)CN1C1=NC(CC=2C=CC=CC=2)=C(I)C=C1Cl PHCXYSFEITYKCD-HZPDHXFCSA-N 0.000 description 1
- BHKRTRSHQHFDEZ-IAGOWNOFSA-N (3r,4r)-1-(6-benzylpyridin-2-yl)-4-(methoxymethoxy)pyrrolidin-3-ol Chemical compound C1[C@@H](O)[C@H](OCOC)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 BHKRTRSHQHFDEZ-IAGOWNOFSA-N 0.000 description 1
- YGEJSHHOQYHSPQ-HZPDHXFCSA-N (3r,4r)-1-(6-benzylpyridin-2-yl)-4-methoxypyrrolidin-3-ol Chemical compound C1[C@@H](O)[C@H](OC)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 YGEJSHHOQYHSPQ-HZPDHXFCSA-N 0.000 description 1
- SQNMPGYCNXLWIN-RNFRBKRXSA-N (3r,4r)-1-(6-bromopyridin-2-yl)pyrrolidine-3,4-diol Chemical compound C1[C@@H](O)[C@H](O)CN1C1=CC=CC(Br)=N1 SQNMPGYCNXLWIN-RNFRBKRXSA-N 0.000 description 1
- IUMHWJNSZIXXSB-SWLSCSKDSA-N (3r,4s)-1-(6-benzyl-5-iodopyridin-2-yl)-4-fluoropyrrolidin-3-ol Chemical compound C1[C@H](F)[C@H](O)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 IUMHWJNSZIXXSB-SWLSCSKDSA-N 0.000 description 1
- SDIGCJPJDADGQP-CVEARBPZSA-N (3r,4s)-1-(6-benzyl-5-iodopyridin-2-yl)-4-methoxypyrrolidin-3-ol Chemical compound C1[C@@H](O)[C@@H](OC)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 SDIGCJPJDADGQP-CVEARBPZSA-N 0.000 description 1
- YQMXOIAIYXXXEE-NSHDSACASA-N (3s)-1-benzylpyrrolidin-3-ol Chemical compound C1[C@@H](O)CCN1CC1=CC=CC=C1 YQMXOIAIYXXXEE-NSHDSACASA-N 0.000 description 1
- YRTHQTAVIFQEEG-VIFPVBQESA-N (3s)-3-ethynyl-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CC2[C@](O)(C#C)CN1CC2 YRTHQTAVIFQEEG-VIFPVBQESA-N 0.000 description 1
- SDIGCJPJDADGQP-HOTGVXAUSA-N (3s,4s)-1-(6-benzyl-5-iodopyridin-2-yl)-4-methoxypyrrolidin-3-ol Chemical compound C1[C@H](O)[C@@H](OC)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 SDIGCJPJDADGQP-HOTGVXAUSA-N 0.000 description 1
- KQQWMDCMXOEVAD-GJZGRUSLSA-N (3s,4s)-1-(6-benzylpyridin-2-yl)pyrrolidine-3,4-diol Chemical compound C1[C@H](O)[C@@H](O)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 KQQWMDCMXOEVAD-GJZGRUSLSA-N 0.000 description 1
- UOGHLQFIXFHXPX-UHFFFAOYSA-N (4-methoxyphenyl)-(6-methyl-3-phenylmethoxypyridin-2-yl)methanol Chemical compound C1=CC(OC)=CC=C1C(O)C1=NC(C)=CC=C1OCC1=CC=CC=C1 UOGHLQFIXFHXPX-UHFFFAOYSA-N 0.000 description 1
- DQZVSPWTLTUUDY-IAGOWNOFSA-N (4ar,7ar)-6-(6-benzylpyridin-2-yl)-2,3,4a,5,7,7a-hexahydro-[1,4]dioxino[2,3-c]pyrrole Chemical compound C=1C=CC(N2C[C@H]3OCCO[C@@H]3C2)=NC=1CC1=CC=CC=C1 DQZVSPWTLTUUDY-IAGOWNOFSA-N 0.000 description 1
- UWGLWBDGGVYHIE-RKDXNWHRSA-N (4ar,7ar)-6-(6-bromopyridin-2-yl)-2,3,4a,5,7,7a-hexahydro-[1,4]dioxino[2,3-c]pyrrole Chemical compound BrC1=CC=CC(N2C[C@H]3OCCO[C@@H]3C2)=N1 UWGLWBDGGVYHIE-RKDXNWHRSA-N 0.000 description 1
- RLMROKWPWQUZEK-UHFFFAOYSA-N (6-chloro-2-methoxypyridin-3-yl)-phenylmethanol Chemical compound COC1=NC(Cl)=CC=C1C(O)C1=CC=CC=C1 RLMROKWPWQUZEK-UHFFFAOYSA-N 0.000 description 1
- 125000006553 (C3-C8) cycloalkenyl group Chemical group 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- 125000005923 1,2-dimethylpropyloxy group Chemical group 0.000 description 1
- 125000004720 1,2-dimethylpropylthio group Chemical group CC(C(C)C)S* 0.000 description 1
- QUKGLNCXGVWCJX-UHFFFAOYSA-N 1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=CS1 QUKGLNCXGVWCJX-UHFFFAOYSA-N 0.000 description 1
- 125000004727 1,3-dimethylbutylthio group Chemical group CC(CC(C)C)S* 0.000 description 1
- VKRKCBWIVLSRBJ-UHFFFAOYSA-N 1,4-dioxaspiro[4.5]decan-8-one Chemical compound C1CC(=O)CCC21OCCO2 VKRKCBWIVLSRBJ-UHFFFAOYSA-N 0.000 description 1
- XBDXMDVEZLOGMC-UHFFFAOYSA-N 1-(chloromethyl)-3-fluorobenzene Chemical compound FC1=CC=CC(CCl)=C1 XBDXMDVEZLOGMC-UHFFFAOYSA-N 0.000 description 1
- IZXWCDITFDNEBY-UHFFFAOYSA-N 1-(chloromethyl)-4-fluorobenzene Chemical compound FC1=CC=C(CCl)C=C1 IZXWCDITFDNEBY-UHFFFAOYSA-N 0.000 description 1
- SMGURJQPNXWSTL-UHFFFAOYSA-N 1-dimethoxyphosphoryl-3-methoxypropan-2-one Chemical compound COCC(=O)CP(=O)(OC)OC SMGURJQPNXWSTL-UHFFFAOYSA-N 0.000 description 1
- ZVYKGGUDGOFMCF-UHFFFAOYSA-N 1-ethoxyethanol;sodium Chemical compound [Na].CCOC(C)O ZVYKGGUDGOFMCF-UHFFFAOYSA-N 0.000 description 1
- LQMDOONLLAJAPZ-UHFFFAOYSA-N 1-ethynylcyclopentan-1-ol Chemical compound C#CC1(O)CCCC1 LQMDOONLLAJAPZ-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- 125000004728 2,2-dimethylbutylthio group Chemical group CC(CS*)(CC)C 0.000 description 1
- PAGTXDLKXRBHFL-UHFFFAOYSA-N 2-(hydroxymethyl)-6-methylpyridin-3-ol Chemical compound CC1=CC=C(O)C(CO)=N1 PAGTXDLKXRBHFL-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- GUNKVEDESTYGCW-GHMZBOCLSA-N 2-[(3r,4r)-1-(6-bromopyridin-2-yl)-4-(methoxymethoxy)pyrrolidin-3-yl]oxyethanol Chemical compound C1[C@@H](OCCO)[C@H](OCOC)CN1C1=CC=CC(Br)=N1 GUNKVEDESTYGCW-GHMZBOCLSA-N 0.000 description 1
- ZIBHXDZLQBCXEL-VXGBXAGGSA-N 2-[(3r,4r)-1-(6-bromopyridin-2-yl)-4-(methoxymethoxy)pyrrolidin-3-yl]oxyethyl methanesulfonate Chemical compound C1[C@@H](OCCOS(C)(=O)=O)[C@H](OCOC)CN1C1=CC=CC(Br)=N1 ZIBHXDZLQBCXEL-VXGBXAGGSA-N 0.000 description 1
- KJGHHUUESDTSKB-NXEZZACHSA-N 2-[(3r,4r)-1-(6-bromopyridin-2-yl)-4-hydroxypyrrolidin-3-yl]oxyethyl methanesulfonate Chemical compound C1[C@@H](O)[C@H](OCCOS(=O)(=O)C)CN1C1=CC=CC(Br)=N1 KJGHHUUESDTSKB-NXEZZACHSA-N 0.000 description 1
- DYSXLWJUOCEHKB-UHFFFAOYSA-N 2-benzyl-3-(methoxymethoxy)-6-(3-methoxypropyl)pyridine Chemical compound COCCCC1=CC=C(OCOC)C(CC=2C=CC=CC=2)=N1 DYSXLWJUOCEHKB-UHFFFAOYSA-N 0.000 description 1
- PQJLRQSYEQLNJO-UHFFFAOYSA-N 2-benzyl-3-(methoxymethoxy)-6-(oxan-4-yl)pyridine Chemical compound COCOC1=CC=C(C2CCOCC2)N=C1CC1=CC=CC=C1 PQJLRQSYEQLNJO-UHFFFAOYSA-N 0.000 description 1
- WGBOIGIDSPJFPS-UHFFFAOYSA-N 2-benzyl-6-(3,6-dihydro-2h-pyran-4-yl)-3-(methoxymethoxy)pyridine Chemical compound COCOC1=CC=C(C=2CCOCC=2)N=C1CC1=CC=CC=C1 WGBOIGIDSPJFPS-UHFFFAOYSA-N 0.000 description 1
- RTDLQBLKCQTEEZ-CHWSQXEVSA-N 2-benzyl-6-[(3r,4r)-3,4-difluoropyrrolidin-1-yl]-3-iodopyridine Chemical compound C1[C@@H](F)[C@H](F)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 RTDLQBLKCQTEEZ-CHWSQXEVSA-N 0.000 description 1
- DDIOQJJYEVYIND-HUUCEWRRSA-N 2-benzyl-6-[(3r,4r)-3,4-difluoropyrrolidin-1-yl]pyridine Chemical compound C1[C@@H](F)[C@H](F)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 DDIOQJJYEVYIND-HUUCEWRRSA-N 0.000 description 1
- DBCXUSSLLCHWFH-WOJBJXKFSA-N 2-benzyl-6-[(3r,4r)-3-cyclopropyloxy-4-(methoxymethoxy)pyrrolidin-1-yl]pyridine Chemical compound O([C@@H]1CN(C[C@H]1OCOC)C=1N=C(CC=2C=CC=CC=2)C=CC=1)C1CC1 DBCXUSSLLCHWFH-WOJBJXKFSA-N 0.000 description 1
- BOCBXYFTZZYYRG-RTBURBONSA-N 2-benzyl-6-[(3r,4r)-3-ethenoxy-4-(methoxymethoxy)pyrrolidin-1-yl]pyridine Chemical compound C1[C@@H](OC=C)[C@H](OCOC)CN1C1=CC=CC(CC=2C=CC=CC=2)=N1 BOCBXYFTZZYYRG-RTBURBONSA-N 0.000 description 1
- XZMHQTHHHPXNCJ-DLBZAZTESA-N 2-benzyl-6-[(3r,4s)-3-(fluoromethoxy)-4-methoxypyrrolidin-1-yl]-3-iodopyridine Chemical compound C1[C@@H](OCF)[C@@H](OC)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 XZMHQTHHHPXNCJ-DLBZAZTESA-N 0.000 description 1
- PIPOIWNEESZXAP-XJKSGUPXSA-N 2-benzyl-6-[(3s,4r)-3-chloro-4-methoxypyrrolidin-1-yl]-3-iodopyridine Chemical compound C1[C@H](Cl)[C@H](OC)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 PIPOIWNEESZXAP-XJKSGUPXSA-N 0.000 description 1
- DIZSCXUEFRNQCQ-WMLDXEAASA-N 2-benzyl-6-[(3s,4r)-3-fluoro-4-(methoxymethoxy)pyrrolidin-1-yl]-3-iodopyridine Chemical compound C1[C@H](F)[C@H](OCOC)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 DIZSCXUEFRNQCQ-WMLDXEAASA-N 0.000 description 1
- RRTLQRYOJOSPEA-UHFFFAOYSA-N 2-bromo-1,3,5-trimethylbenzene Chemical group CC1=CC(C)=C(Br)C(C)=C1 RRTLQRYOJOSPEA-UHFFFAOYSA-N 0.000 description 1
- VAVGOGHLNAJECD-UHFFFAOYSA-N 2-chloro-6-methoxypyridine Chemical compound COC1=CC=CC(Cl)=N1 VAVGOGHLNAJECD-UHFFFAOYSA-N 0.000 description 1
- RXTRRIFWCJEMEL-UHFFFAOYSA-N 2-chloropyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1Cl RXTRRIFWCJEMEL-UHFFFAOYSA-N 0.000 description 1
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 description 1
- 125000003858 2-ethylbutoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])O*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- KQDJTBPASNJQFQ-UHFFFAOYSA-N 2-iodophenol Chemical compound OC1=CC=CC=C1I KQDJTBPASNJQFQ-UHFFFAOYSA-N 0.000 description 1
- CSTLUDXZDHQVDZ-UHFFFAOYSA-N 2-methoxy-3-(thiophen-2-ylmethyl)pyridine Chemical compound COC1=NC=CC=C1CC1=CC=CS1 CSTLUDXZDHQVDZ-UHFFFAOYSA-N 0.000 description 1
- ICPWFHKNYYRBSZ-UHFFFAOYSA-M 2-methoxypropanoate Chemical compound COC(C)C([O-])=O ICPWFHKNYYRBSZ-UHFFFAOYSA-M 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000005924 2-methylpentyloxy group Chemical group 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- BKPVCXHRHAGUMC-UHFFFAOYSA-N 3-[2-(2-benzyl-6-pyridin-3-ylpyridin-3-yl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1N(CC2)CCC2C1(O)C#CC1=CC=C(C=2C=NC=CC=2)N=C1CC1=CC=CC=C1 BKPVCXHRHAGUMC-UHFFFAOYSA-N 0.000 description 1
- TXPLBEPBQCSQHJ-UHFFFAOYSA-N 3-[2-benzyl-6-(3-methoxypropoxy)pyridin-3-yl]-2-ethynyl-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C(C1=CC=CC=C1)C1=NC(=CC=C1C1(C(N2CCC1CC2)C#C)O)OCCCOC TXPLBEPBQCSQHJ-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- YACFFSVYSPMSGS-UHFFFAOYSA-N 3-methoxyprop-1-yne Chemical compound COCC#C YACFFSVYSPMSGS-UHFFFAOYSA-N 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- 125000005925 3-methylpentyloxy group Chemical group 0.000 description 1
- FVVRPZIBCRWPLF-UHFFFAOYSA-N 3-tributylstannylcyclohex-2-en-1-one Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC(=O)CCC1 FVVRPZIBCRWPLF-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- XUGISPSHIFXEHZ-UHFFFAOYSA-N 3beta-acetoxy-cholest-5-ene Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XUGISPSHIFXEHZ-UHFFFAOYSA-N 0.000 description 1
- LPHYIXXIBUJZSO-UHFFFAOYSA-N 4-[5-benzyl-6-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]pyridin-3-yl]butan-2-one;hydrochloride Chemical compound Cl.C=1C(CCC(=O)C)=CN=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 LPHYIXXIBUJZSO-UHFFFAOYSA-N 0.000 description 1
- KEWFQOBUXAEZJS-UHFFFAOYSA-N 4-benzyl-5-bromo-2-chloropyrimidine Chemical compound ClC1=NC=C(Br)C(CC=2C=CC=CC=2)=N1 KEWFQOBUXAEZJS-UHFFFAOYSA-N 0.000 description 1
- QJPJQTDYNZXKQF-UHFFFAOYSA-N 4-bromoanisole Chemical compound COC1=CC=C(Br)C=C1 QJPJQTDYNZXKQF-UHFFFAOYSA-N 0.000 description 1
- MPZMVUQGXAOJIK-UHFFFAOYSA-N 4-bromopyridine;hydron;chloride Chemical compound Cl.BrC1=CC=NC=C1 MPZMVUQGXAOJIK-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- KXXBKFCHLJPITK-UHFFFAOYSA-N 5-bromo-6-[(3-fluorophenyl)methyl]-1h-pyridin-2-one Chemical compound OC1=CC=C(Br)C(CC=2C=C(F)C=CC=2)=N1 KXXBKFCHLJPITK-UHFFFAOYSA-N 0.000 description 1
- OVFQDWYYLJCSJG-UHFFFAOYSA-N 5-bromo-6-[(4-fluorophenyl)methyl]-1h-pyridin-2-one Chemical compound OC1=CC=C(Br)C(CC=2C=CC(F)=CC=2)=N1 OVFQDWYYLJCSJG-UHFFFAOYSA-N 0.000 description 1
- STIYANMAWBSEIZ-UHFFFAOYSA-N 6-benzyl-5-bromo-3-iodo-1h-pyridin-2-one Chemical compound C1=C(I)C(O)=NC(CC=2C=CC=CC=2)=C1Br STIYANMAWBSEIZ-UHFFFAOYSA-N 0.000 description 1
- XYKGZOGRIPBICU-UHFFFAOYSA-N 6-methyl-2-(2-phenylethenyl)pyridin-3-ol Chemical compound CC1=CC=C(O)C(C=CC=2C=CC=CC=2)=N1 XYKGZOGRIPBICU-UHFFFAOYSA-N 0.000 description 1
- LYFAOQONLODROU-AREMUKBSSA-N 7-[6-benzyl-5-[2-[(3r)-3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl]ethynyl]pyridin-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonan-6-one Chemical compound C([C@@]1(C2CCN(CC2)C1)O)#CC1=CC=C(N2C(C3(OCCO3)CC2)=O)N=C1CC1=CC=CC=C1 LYFAOQONLODROU-AREMUKBSSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- UUNXSYZNIVLXLM-UHFFFAOYSA-N CC(C(CP(O)(O)=O)=O)(OC)C Chemical compound CC(C(CP(O)(O)=O)=O)(OC)C UUNXSYZNIVLXLM-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Chemical group 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical class F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical class NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- FWFNDAJLXUCRKS-UHFFFAOYSA-N [(2-methoxypyridin-4-yl)-phenylmethyl] acetate Chemical compound C1=NC(OC)=CC(C(OC(C)=O)C=2C=CC=CC=2)=C1 FWFNDAJLXUCRKS-UHFFFAOYSA-N 0.000 description 1
- KXHIXDIQNBAGDS-FGZHOGPDSA-N [(3r,4r)-1-(6-benzyl-5-iodopyridin-2-yl)-4-methoxypyrrolidin-3-yl] 3-nitrobenzenesulfonate Chemical compound O([C@@H]1CN(C[C@H]1OC)C=1N=C(CC=2C=CC=CC=2)C(I)=CC=1)S(=O)(=O)C1=CC=CC([N+]([O-])=O)=C1 KXHIXDIQNBAGDS-FGZHOGPDSA-N 0.000 description 1
- KNZIDKXJEJEBJE-ZWKOTPCHSA-N [(3r,4s)-1-(6-benzyl-5-iodopyridin-2-yl)-4-methoxypyrrolidin-3-yl] acetate Chemical compound C1[C@@H](OC(C)=O)[C@@H](OC)CN1C1=CC=C(I)C(CC=2C=CC=CC=2)=N1 KNZIDKXJEJEBJE-ZWKOTPCHSA-N 0.000 description 1
- KXHIXDIQNBAGDS-VXKWHMMOSA-N [(3s,4s)-1-(6-benzyl-5-iodopyridin-2-yl)-4-methoxypyrrolidin-3-yl] 3-nitrobenzenesulfonate Chemical compound O([C@H]1CN(C[C@@H]1OC)C=1N=C(CC=2C=CC=CC=2)C(I)=CC=1)S(=O)(=O)C1=CC=CC([N+]([O-])=O)=C1 KXHIXDIQNBAGDS-VXKWHMMOSA-N 0.000 description 1
- IWSWJHHCIWPQRJ-UHFFFAOYSA-N [2-(2-methoxyethoxy)pyridin-4-yl]-phenylmethanol Chemical compound C1=NC(OCCOC)=CC(C(O)C=2C=CC=CC=2)=C1 IWSWJHHCIWPQRJ-UHFFFAOYSA-N 0.000 description 1
- FMGZMZHZVYTVCA-UHFFFAOYSA-N [2-benzyl-6-(3,6-dihydro-2h-pyran-4-yl)pyridin-3-yl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=C(C=2CCOCC=2)N=C1CC1=CC=CC=C1 FMGZMZHZVYTVCA-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical class N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
- JUCVMCNRABNRJD-UHFFFAOYSA-N azane;ethyl acetate Chemical compound N.CCOC(C)=O JUCVMCNRABNRJD-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical class C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008687 biosynthesis inhibition Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- MOOAHMCRPCTRLV-UHFFFAOYSA-N boron sodium Chemical class [B].[Na] MOOAHMCRPCTRLV-UHFFFAOYSA-N 0.000 description 1
- VHYZKKUPEOKTPC-UHFFFAOYSA-N bromomethylbenzene;magnesium Chemical compound [Mg].BrCC1=CC=CC=C1 VHYZKKUPEOKTPC-UHFFFAOYSA-N 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- DCUKIPCLKPKATJ-UHFFFAOYSA-N chloromethylbenzene;magnesium Chemical compound [Mg].ClCC1=CC=CC=C1 DCUKIPCLKPKATJ-UHFFFAOYSA-N 0.000 description 1
- XUGISPSHIFXEHZ-VEVYEIKRSA-N cholesteryl acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XUGISPSHIFXEHZ-VEVYEIKRSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 229960001270 d- tartaric acid Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- AIPRAPZUGUTQKX-UHFFFAOYSA-N diethoxyphosphorylmethylbenzene Chemical compound CCOP(=O)(OCC)CC1=CC=CC=C1 AIPRAPZUGUTQKX-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- ZHXTWWCDMUWMDI-UHFFFAOYSA-N dihydroxyboron Chemical compound O[B]O ZHXTWWCDMUWMDI-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VONWDASPFIQPDY-UHFFFAOYSA-N dimethyl methylphosphonate Chemical compound COP(C)(=O)OC VONWDASPFIQPDY-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 150000002031 dolichols Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003221 ear drop Substances 0.000 description 1
- 229940047652 ear drops Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical class I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- AUONNNVJUCSETH-UHFFFAOYSA-N icosanoyl icosanoate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCCCC AUONNNVJUCSETH-UHFFFAOYSA-N 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- SCEZYJKGDJPHQO-UHFFFAOYSA-M magnesium;methanidylbenzene;chloride Chemical compound [Mg+2].[Cl-].[CH2-]C1=CC=CC=C1 SCEZYJKGDJPHQO-UHFFFAOYSA-M 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- VHWYCFISAQVCCP-UHFFFAOYSA-N methoxymethanol Chemical compound COCO VHWYCFISAQVCCP-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- OMSFDLOQEBGAQX-UHFFFAOYSA-N n-(5-benzyl-6-methoxypyridin-3-yl)-n-methylbenzamide Chemical compound COC1=NC=C(N(C)C(=O)C=2C=CC=CC=2)C=C1CC1=CC=CC=C1 OMSFDLOQEBGAQX-UHFFFAOYSA-N 0.000 description 1
- HNQPDHBFUDVEAV-UHFFFAOYSA-N n-(6-amino-7h-purin-2-yl)pyridine-3-carboxamide Chemical compound N=1C=2N=CNC=2C(N)=NC=1NC(=O)C1=CC=CN=C1 HNQPDHBFUDVEAV-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- MNTFGVITEIRMTH-UHFFFAOYSA-N n-[5-benzyl-6-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]pyridin-3-yl]-n-methylbenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C(C=1)=CN=C(C#CC2(O)C3CCN(CC3)C2)C=1CC1=CC=CC=C1 MNTFGVITEIRMTH-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004708 n-butylthio group Chemical group C(CCC)S* 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000003935 n-pentoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004706 n-propylthio group Chemical group C(CC)S* 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940069265 ophthalmic ointment Drugs 0.000 description 1
- 229940054534 ophthalmic solution Drugs 0.000 description 1
- 239000002997 ophthalmic solution Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical class CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000005920 sec-butoxy group Chemical group 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- XSJMFOLJINEZRD-UHFFFAOYSA-N tert-butyl 2-(dimethylaminomethylidene)-3-oxo-4-phenylbutanoate Chemical compound CC(C)(C)OC(=O)C(=CN(C)C)C(=O)CC1=CC=CC=C1 XSJMFOLJINEZRD-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 1
- 239000012414 tert-butyl nitrite Substances 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- UNWZKBKTIYBBRV-UHFFFAOYSA-N tetraazanium;tetrachloride Chemical compound [NH4+].[NH4+].[NH4+].[NH4+].[Cl-].[Cl-].[Cl-].[Cl-] UNWZKBKTIYBBRV-UHFFFAOYSA-N 0.000 description 1
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M toluenesulfonate group Chemical group C=1(C(=CC=CC1)S(=O)(=O)[O-])C LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- ZQMLPLBDZBCQCV-UHFFFAOYSA-N tributyl(3,4-dihydro-2h-pyran-6-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CCCCO1 ZQMLPLBDZBCQCV-UHFFFAOYSA-N 0.000 description 1
- YLGRTLMDMVAFNI-UHFFFAOYSA-N tributyl(prop-2-enyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)CC=C YLGRTLMDMVAFNI-UHFFFAOYSA-N 0.000 description 1
- DBHSVKZZSWTSTN-UHFFFAOYSA-N tributyl(pyridazin-3-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CN=N1 DBHSVKZZSWTSTN-UHFFFAOYSA-N 0.000 description 1
- UDLLSOQWYYRFPP-UHFFFAOYSA-N tributyl(pyridazin-4-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=NN=C1 UDLLSOQWYYRFPP-UHFFFAOYSA-N 0.000 description 1
- HQMLIWXIPSYXMY-UHFFFAOYSA-N tributyl(pyrimidin-4-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=NC=N1 HQMLIWXIPSYXMY-UHFFFAOYSA-N 0.000 description 1
- QRDQHTJNKPXXRQ-UHFFFAOYSA-N tributyl(pyrimidin-5-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CN=CN=C1 QRDQHTJNKPXXRQ-UHFFFAOYSA-N 0.000 description 1
- 125000002827 triflate group Chemical class FC(S(=O)(=O)O*)(F)F 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27390599 | 1999-09-28 | ||
JP2000179352 | 2000-06-15 | ||
PCT/JP2000/006665 WO2001023383A1 (fr) | 1999-09-28 | 2000-09-27 | Composes de quinuclidine et medicaments contenant ces composes comme principe actif |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20021528D0 NO20021528D0 (no) | 2002-03-26 |
NO20021528L NO20021528L (no) | 2002-05-28 |
NO328218B1 true NO328218B1 (no) | 2010-01-11 |
Family
ID=26550809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021528A NO328218B1 (no) | 1999-09-28 | 2002-03-26 | Kinuklidinforbindelser, anvendelse derav, fremgangsmater for fremstilling derav, og medisinske preparater omfattende slike |
Country Status (20)
Country | Link |
---|---|
US (1) | US6599917B1 (ko) |
EP (1) | EP1217001B1 (ko) |
JP (1) | JP4206212B2 (ko) |
KR (1) | KR100694687B1 (ko) |
CN (1) | CN100334085C (ko) |
AT (1) | ATE312100T1 (ko) |
AU (1) | AU782114B2 (ko) |
BR (1) | BR0014331A (ko) |
CA (1) | CA2385995C (ko) |
DE (1) | DE60024651T2 (ko) |
DK (1) | DK1217001T3 (ko) |
ES (1) | ES2252063T3 (ko) |
HU (1) | HUP0203514A3 (ko) |
IL (2) | IL148631A0 (ko) |
MX (1) | MXPA02003167A (ko) |
NO (1) | NO328218B1 (ko) |
NZ (1) | NZ517788A (ko) |
RU (1) | RU2266905C2 (ko) |
TW (1) | TWI282794B (ko) |
WO (1) | WO2001023383A1 (ko) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0010955D0 (en) * | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
ATE366248T1 (de) | 2001-03-27 | 2007-07-15 | Eisai R&D Man Co Ltd | N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält |
EP1256573A1 (en) | 2001-05-09 | 2002-11-13 | Eisai Co., Ltd. | Process for producing stereoisomer of pyrrolidine derivative |
RU2004110717A (ru) * | 2001-10-17 | 2005-10-20 | Юсиби, С.А. (Be) | Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов |
US7361671B2 (en) * | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
DE10225537A1 (de) * | 2002-06-10 | 2003-12-18 | Bayer Ag | N-alkylierte Thiazoliumsalze und Verfahren zu deren Herstellung |
GB0218876D0 (en) * | 2002-08-13 | 2002-09-25 | Merck Sharp & Dohme | Therapeutic agents |
AU2003276919B2 (en) | 2002-09-25 | 2013-05-16 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
DE10334724A1 (de) * | 2003-07-30 | 2005-02-24 | Bayer Healthcare Ag | N-Biarylamide |
TW200526631A (en) * | 2003-10-07 | 2005-08-16 | Renovis Inc | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
CN103724343A (zh) | 2004-03-25 | 2014-04-16 | 记忆药物公司 | 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑及其制备和用途 |
US8106066B2 (en) | 2005-09-23 | 2012-01-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
JP2010519328A (ja) | 2007-02-26 | 2010-06-03 | ファイザー・プロダクツ・インク | H−pgdsの阻害剤としてのニコチンアミド誘導体およびプロスタグランジンd2が媒介する疾患の治療のためのそれらの使用 |
TW201111385A (en) | 2009-08-27 | 2011-04-01 | Biocryst Pharm Inc | Heterocyclic compounds as janus kinase inhibitors |
US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
AR081428A1 (es) | 2010-05-28 | 2012-08-29 | Biocryst Pharm Inc | Derivados heterociclicos condensados nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para suprimir una respuesta inmune o tratar cancer. |
SI3141542T1 (sl) | 2011-12-28 | 2020-11-30 | Global Blood Therapeutics, Inc. | Substituirane spojine benzaldehida in metode njihove uporabe pri povečanju oksigenacije tkiva |
WO2013102145A1 (en) | 2011-12-28 | 2013-07-04 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
EP2914587A1 (de) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
CN105073728A (zh) | 2013-03-15 | 2015-11-18 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
WO2014145040A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
KR101971385B1 (ko) | 2013-03-15 | 2019-04-22 | 글로벌 블러드 테라퓨틱스, 인크. | 헤모글로빈 조정을 위한 화합물 및 이의 용도 |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
CN105246477A (zh) | 2013-03-15 | 2016-01-13 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
EA202092627A1 (ru) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
EA028529B1 (ru) | 2014-02-07 | 2017-11-30 | Глобал Блад Терапьютикс, Инк. | Кристаллические полиморфные формы свободного основания 2-гидрокси-6-((2-(1-изопропил-1н-пиразол-5-ил)пиридин-3-ил)метокси)бензальдегида |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
AU2016273751B2 (en) | 2015-06-03 | 2020-04-02 | F. Hoffmann-La Roche Ag | Ethynyl derivatives |
MX2018006832A (es) | 2015-12-04 | 2018-11-09 | Global Blood Therapeutics Inc | Regimenes de dosificacion de 2-hidroxi-6-((2-(1-isopropil-1h-piraz ol-5-il)-piridin-3-il)-metoxi)-benzaldehido. |
TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
CA3113234A1 (en) | 2018-09-18 | 2020-03-26 | Nikang Therapeutics, Inc. | Tri-substituted heteroaryl derivatives as src homology-2 phosphatase inhibitors |
EP3860975B1 (en) | 2018-10-01 | 2023-10-18 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin for the treatment of sickle cell disease |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015579A1 (en) * | 1991-03-08 | 1992-09-17 | Rhone-Poulenc Rorer International (Holdings) Inc. | Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
US5135935A (en) * | 1991-05-17 | 1992-08-04 | Merck & Co., Inc. | Squalene synthetase inhibitors |
GB9127279D0 (en) | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
JPH05310732A (ja) * | 1992-03-12 | 1993-11-22 | Mitsubishi Kasei Corp | シンノリン−3−カルボン酸誘導体 |
GB9207961D0 (en) * | 1992-04-10 | 1992-05-27 | Ici Plc | Heterocyclic derivatives |
GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
WO1995031458A1 (en) | 1992-10-13 | 1995-11-23 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | 3-hydroxyquinuclidin-3-ylphenylquinolines as squalene synthase inhibitors |
GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
IL109451A0 (en) | 1993-04-29 | 1994-07-31 | Zeneca Ltd | Heterocyclic derivatives |
GB9412145D0 (en) * | 1994-06-17 | 1994-08-10 | Zeneca Ltd | Heterocycles |
JPH08134067A (ja) * | 1994-11-11 | 1996-05-28 | Yamanouchi Pharmaceut Co Ltd | キヌクリジン誘導体 |
JPH08269056A (ja) * | 1995-03-29 | 1996-10-15 | Chugai Pharmaceut Co Ltd | スクアレンシンセターゼ阻害作用を有するキヌクリジン誘導体 |
US5712270A (en) * | 1995-11-06 | 1998-01-27 | American Home Products Corporation | 2-arylamidothiazole derivatives with CNS activity |
WO1997044339A1 (en) * | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
2000
- 2000-09-27 MX MXPA02003167A patent/MXPA02003167A/es active IP Right Grant
- 2000-09-27 BR BR0014331-6A patent/BR0014331A/pt not_active Application Discontinuation
- 2000-09-27 EP EP00962889A patent/EP1217001B1/en not_active Expired - Lifetime
- 2000-09-27 AT AT00962889T patent/ATE312100T1/de not_active IP Right Cessation
- 2000-09-27 AU AU74464/00A patent/AU782114B2/en not_active Ceased
- 2000-09-27 NZ NZ517788A patent/NZ517788A/en not_active IP Right Cessation
- 2000-09-27 CN CNB00813541XA patent/CN100334085C/zh not_active Expired - Fee Related
- 2000-09-27 IL IL14863100A patent/IL148631A0/xx unknown
- 2000-09-27 ES ES00962889T patent/ES2252063T3/es not_active Expired - Lifetime
- 2000-09-27 JP JP2001526535A patent/JP4206212B2/ja not_active Expired - Fee Related
- 2000-09-27 KR KR1020027003952A patent/KR100694687B1/ko not_active IP Right Cessation
- 2000-09-27 WO PCT/JP2000/006665 patent/WO2001023383A1/ja active IP Right Grant
- 2000-09-27 DK DK00962889T patent/DK1217001T3/da active
- 2000-09-27 HU HU0203514A patent/HUP0203514A3/hu unknown
- 2000-09-27 DE DE60024651T patent/DE60024651T2/de not_active Expired - Lifetime
- 2000-09-27 US US10/088,554 patent/US6599917B1/en not_active Expired - Fee Related
- 2000-09-27 CA CA002385995A patent/CA2385995C/en not_active Expired - Fee Related
- 2000-09-27 TW TW089119958A patent/TWI282794B/zh not_active IP Right Cessation
- 2000-09-27 RU RU2002111344/04A patent/RU2266905C2/ru not_active IP Right Cessation
-
2002
- 2002-03-12 IL IL148631A patent/IL148631A/en not_active IP Right Cessation
- 2002-03-26 NO NO20021528A patent/NO328218B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60024651T2 (de) | 2006-09-28 |
KR20020034197A (ko) | 2002-05-08 |
AU782114B2 (en) | 2005-07-07 |
IL148631A (en) | 2010-04-29 |
CN1377349A (zh) | 2002-10-30 |
HUP0203514A3 (en) | 2004-01-28 |
NZ517788A (en) | 2003-11-28 |
AU7446400A (en) | 2001-04-30 |
DE60024651D1 (de) | 2006-01-12 |
TWI282794B (en) | 2007-06-21 |
ES2252063T3 (es) | 2006-05-16 |
JP4206212B2 (ja) | 2009-01-07 |
CA2385995C (en) | 2009-06-16 |
KR100694687B1 (ko) | 2007-03-13 |
CN100334085C (zh) | 2007-08-29 |
HUP0203514A2 (hu) | 2003-03-28 |
WO2001023383A1 (fr) | 2001-04-05 |
EP1217001A4 (en) | 2002-12-18 |
NO20021528L (no) | 2002-05-28 |
EP1217001B1 (en) | 2005-12-07 |
ATE312100T1 (de) | 2005-12-15 |
NO20021528D0 (no) | 2002-03-26 |
DK1217001T3 (da) | 2006-03-20 |
EP1217001A1 (en) | 2002-06-26 |
MXPA02003167A (es) | 2003-10-06 |
IL148631A0 (en) | 2002-09-12 |
BR0014331A (pt) | 2003-06-10 |
RU2266905C2 (ru) | 2005-12-27 |
CA2385995A1 (en) | 2001-04-05 |
US6599917B1 (en) | 2003-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1217001B1 (en) | Quinuclidine compounds and drugs containing the same as the active ingredient | |
US11319309B2 (en) | Cyclohexyl acid isoxazole azines as LPA antagonists | |
EP3507289B1 (en) | Muscarinic m1 receptor positive allosteric modulators | |
CN104619709B (zh) | 作为tnf活性调节剂的咪唑并吡啶衍生物 | |
WO2019126090A1 (en) | Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists | |
EP3728210A1 (en) | Isoxazole n-linked carbamoyl cyclohexyl acids as lpa antagonists | |
AU2017339839A1 (en) | Substituted pyrrolidines as CFTR modulators | |
AU2017339249A1 (en) | Substituted pyrrolidines and their use in the treatment of cystic fiibrosis | |
JP2022545359A (ja) | 嚢胞性線維症膜コンダクタンス制御因子モジュレーター | |
EA039808B1 (ru) | Аминотриазолопиридины в качестве ингибиторов киназ | |
US11866446B2 (en) | Inhibitors of APOL1 and methods of using same | |
WO2019126094A1 (en) | Cyclohexyl acid triazole azoles as lpa antagonists | |
WO2019126084A1 (en) | Isoxazole o-linked carbamoyl cyclohexyl acids as lpa antagonists | |
WO2019126085A1 (en) | Pyrazole n-linked carbamoyl cyclohexyl acids as lpa antagonists | |
CN103080106A (zh) | 用作激酶抑制剂的环醚化合物 | |
EP3728222A1 (en) | Cyclohexyl acid pyrazole azines as lpa antagonists | |
AU2014315109A1 (en) | Spirocyclic compounds as tryptophan hydroxylase inhibitors | |
WO2015057626A1 (en) | QUINOLINYL MODULATORS OF RORyT | |
KR102205354B1 (ko) | 역형성 림프종 키나제(alk) 억제제로서의 인돌로퀴놀론 화합물 | |
JP2023536603A (ja) | Fgfr阻害剤化合物及びその使用 | |
EP3345909B1 (en) | Tetrahydrooxepinopyridine compound | |
US20230159523A1 (en) | Pyrazolo[1,5-a]pyridine derivative, preparation method therefor, and composition and use thereof | |
EA035599B1 (ru) | Позитивные аллостерические модуляторы мускариновых m1-рецепторов | |
EA035363B1 (ru) | Замещенные 3-азабицикло[3.1.0]гексаны в качестве ингибиторов кетогексокиназы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |